Marex Group stake now 0% for JRJ-related holders
Marex Group plc received an amended Schedule 13G filing from JRJ Investor 1 LP, Amphitryon Limited (in liquidation), JRJ Group Limited, Sir Jeremy Isaacs and Mr. Roger Nagioff regarding Marex common stock, par value $0.001551 per share.
Rhea-AI Filing Summary
Marex Group plc received an amended Schedule 13G filing from JRJ Investor 1 LP, Amphitryon Limited (in liquidation), JRJ Group Limited, Sir Jeremy Isaacs and Mr. Roger Nagioff regarding Marex common stock, par value $0.001551 per share. The filing states that Amphitryon Limited directly holds 0 shares of Marex and that JRJ Investor 1 LP, JRJ Group Limited, Sir Jeremy Isaacs and Mr. Roger Nagioff may previously have been deemed to share beneficial ownership of shares once held by Amphitryon Limited.
The group now reports 0 shares with 0% of the class, and no sole or shared voting or dispositive power over Marex common stock. The filing confirms they are owners of 5 percent or less of this class of securities.
Positive
- None.
Negative
- None.
Key Figures
Key Terms
beneficial ownership financial
Schedule 13G regulatory
sole voting power financial
dispositive power financial
percent of class financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What change does the Schedule 13G/A report for Marex Group plc (MRX)?
Who are the reporting persons in the Marex Group plc (MRX) Schedule 13G/A?
What percentage of Marex Group plc (MRX) does the JRJ group report owning?
What security is covered in this Marex Group plc (MRX) Schedule 13G/A?
Where are the JRJ reporting entities for Marex Group plc (MRX) organized?
AI-generated analysis. How Rhea-AI works. Not financial advice.